Vascular Access Complications for Therapeutic Apheresis in Nephrology : a Retrospective Observational Study in North-East France.
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- Vascular access Complication (catheter or AVF/AVG thrombosis/infection) rate in therapeutic apheresis among nephrological diseases
研究概览
简要总结
The aim of this study is to describe vascular access complications which are used for therapeutic apheresis in Nephrology.
详细描述
The aim of this study is to describe vascular access complications which are used for therapeutic apheresis in Nephrology.
Complications may include arterio-veinous fistula or graft (AVF or AVG) thrombosis with or without known stenosis; AVF or AVG or central veinous catheter (CVC) infections and CVC dysfunctions.
The investigators may enroll all patients receveing therapeutic apheresis for nephrologic indications in North East France.
Nephrologics indications include :
- acute or active antibody mediated rejection (ABMR),
- Goodpasture disease,
- ANCA vasculitis,
- thrombotic microangiopathy (TMA),
- Focal segmental glomerulosclerosis (FSGS),
- HLA or ABO desensitization for kidney transplantation.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •patients in nephrology receiveing apheresis treatment by filtration or double filtration
排除标准
- •apheresis treatment for other indications
- •centrifugation apheresis treatment
结局指标
主要结局
Vascular access Complication (catheter or AVF/AVG thrombosis/infection) rate in therapeutic apheresis among nephrological diseases
时间窗: june 2020 june 2022
Percent of patient with Vascular access Complication
次要结局
- Comparison of complications rate with literature datas(june 2020 june 2022)
- Description of population enrolled(june 2020 june 2022)
研究者
CORBEL Alice
Dr.CORBEL Alice Nephrology, MD
Central Hospital, Nancy, France